FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3211890524> ?p ?o ?g. }

• W3211890524 endingPage "e0260073" @default.
• W3211890524 startingPage "e0260073" @default.
• W3211890524 abstract "Mainly severe (CTCAE grade 3-4) haematotoxicity during peptide receptor radionuclide therapy (PRRT) is reported in literature due to major clinical impact, however moderate (CTCAE grade 2) haematotoxicity is common and could affect therapy management. The aim of this study was to evaluate the haematotoxicity course during PRRT and to compare baseline parameters between haematotoxicity grades.In this retrospective study, 100 patients with a neuroendocrine tumour treated with PRRT were included. Patients were treated with an aimed number of four cycles with 7.4 GBq [177Lu]Lu-DOTA-TATE administered every 10 weeks. Haematological assessment was performed at baseline and frequently up to 10 weeks after the fourth cycle. The lowest haematological value was graded according to CTCAE v5.0, and patients were classified using the highest observed grade. Differences in baseline parameters, including [68Ga]Ga-DOTA-TATE positive tumour volume, were evaluated between CTCAE grades.Four cycles were completed by 86/100 of patients, 4/100 patients discontinued due to haematotoxicity, and 10/100 patients due to progressive disease. The treatment course was adjusted due to haematotoxicity in 24/100 patients, including postponed next cycle (n = 17), reduced administered activity (n = 13), and both adjustments (n = 10). The most observed haematotoxicity grade was grade 0-1 in 54/100 patients, grade 2 in 38/100 and grade 3-4 in 8/100. Significant differences in baseline leucocyte, neutrophil and platelet counts were observed between grade 0-1 and grade 2. However, the correlation between baseline and lowest observed values was poor to moderate. No differences between haematotoxicity grades and baseline parameters or somatostatin receptor positive tumour volume was observed.The incidence of severe haematotoxicity was low with extensive screening and monitoring. The vast majority of patients (96/100) was not restricted in treatment continuation by haematotoxicity; therefore, our selection criteria appeared appropriate for safe PRRT treatment. Baseline parameters showed limited correlation with the degree of decline in haematological values." @default.
• W3211890524 created "2021-11-22" @default.
• W3211890524 creator A5005680719 @default.
• W3211890524 creator A5005729270 @default.
• W3211890524 creator A5048912946 @default.
• W3211890524 creator A5050665753 @default.
• W3211890524 creator A5054519386 @default.
• W3211890524 creator A5057962780 @default.
• W3211890524 creator A5061515882 @default.
• W3211890524 creator A5065033090 @default.
• W3211890524 creator A5091664083 @default.
• W3211890524 date "2021-11-18" @default.
• W3211890524 modified "2023-10-01" @default.
• W3211890524 title "Haematotoxicity during peptide receptor radionuclide therapy: Baseline parameters differences and effect on patient’s therapy course" @default.
• W3211890524 cites W1967665878 @default.
• W3211890524 cites W1969170786 @default.
• W3211890524 cites W2009041257 @default.
• W3211890524 cites W2019084269 @default.
• W3211890524 cites W2031048655 @default.
• W3211890524 cites W2079633798 @default.
• W3211890524 cites W2088783247 @default.
• W3211890524 cites W2090257199 @default.
• W3211890524 cites W2095354597 @default.
• W3211890524 cites W2108613323 @default.
• W3211890524 cites W2128544796 @default.
• W3211890524 cites W2128596214 @default.
• W3211890524 cites W2522805621 @default.
• W3211890524 cites W2573369749 @default.
• W3211890524 cites W2770481394 @default.
• W3211890524 cites W2783782359 @default.
• W3211890524 cites W2789923927 @default.
• W3211890524 cites W2804721630 @default.
• W3211890524 cites W2805387445 @default.
• W3211890524 cites W2893672803 @default.
• W3211890524 cites W2902656640 @default.
• W3211890524 cites W2968069725 @default.
• W3211890524 cites W3005112928 @default.
• W3211890524 cites W3017335713 @default.
• W3211890524 doi "https://doi.org/10.1371/journal.pone.0260073" @default.
• W3211890524 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8601524" @default.
• W3211890524 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34793530" @default.
• W3211890524 hasPublicationYear "2021" @default.
• W3211890524 type Work @default.
• W3211890524 sameAs 3211890524 @default.
• W3211890524 citedByCount "2" @default.
• W3211890524 countsByYear W32118905242022 @default.
• W3211890524 countsByYear W32118905242023 @default.
• W3211890524 crossrefType "journal-article" @default.
• W3211890524 hasAuthorship W3211890524A5005680719 @default.
• W3211890524 hasAuthorship W3211890524A5005729270 @default.
• W3211890524 hasAuthorship W3211890524A5048912946 @default.
• W3211890524 hasAuthorship W3211890524A5050665753 @default.
• W3211890524 hasAuthorship W3211890524A5054519386 @default.
• W3211890524 hasAuthorship W3211890524A5057962780 @default.
• W3211890524 hasAuthorship W3211890524A5061515882 @default.
• W3211890524 hasAuthorship W3211890524A5065033090 @default.
• W3211890524 hasAuthorship W3211890524A5091664083 @default.
• W3211890524 hasBestOaLocation W32118905241 @default.
• W3211890524 hasConcept C126322002 @default.
• W3211890524 hasConcept C167135981 @default.
• W3211890524 hasConcept C170493617 @default.
• W3211890524 hasConcept C2989005 @default.
• W3211890524 hasConcept C2993559085 @default.
• W3211890524 hasConcept C3017732841 @default.
• W3211890524 hasConcept C71924100 @default.
• W3211890524 hasConcept C90924648 @default.
• W3211890524 hasConceptScore W3211890524C126322002 @default.
• W3211890524 hasConceptScore W3211890524C167135981 @default.
• W3211890524 hasConceptScore W3211890524C170493617 @default.
• W3211890524 hasConceptScore W3211890524C2989005 @default.
• W3211890524 hasConceptScore W3211890524C2993559085 @default.
• W3211890524 hasConceptScore W3211890524C3017732841 @default.
• W3211890524 hasConceptScore W3211890524C71924100 @default.
• W3211890524 hasConceptScore W3211890524C90924648 @default.
• W3211890524 hasIssue "11" @default.
• W3211890524 hasLocation W32118905241 @default.
• W3211890524 hasLocation W32118905242 @default.
• W3211890524 hasLocation W32118905243 @default.
• W3211890524 hasLocation W32118905244 @default.
• W3211890524 hasLocation W32118905245 @default.
• W3211890524 hasOpenAccess W3211890524 @default.
• W3211890524 hasPrimaryLocation W32118905241 @default.
• W3211890524 hasRelatedWork W2076572654 @default.
• W3211890524 hasRelatedWork W2099478219 @default.
• W3211890524 hasRelatedWork W2140602696 @default.
• W3211890524 hasRelatedWork W2157129652 @default.
• W3211890524 hasRelatedWork W2287156935 @default.
• W3211890524 hasRelatedWork W2289763223 @default.
• W3211890524 hasRelatedWork W2492001874 @default.
• W3211890524 hasRelatedWork W2610742364 @default.
• W3211890524 hasRelatedWork W3013180133 @default.
• W3211890524 hasRelatedWork W4205303450 @default.
• W3211890524 hasVolume "16" @default.
• W3211890524 isParatext "false" @default.
• W3211890524 isRetracted "false" @default.
• W3211890524 magId "3211890524" @default.
• W3211890524 workType "article" @default.